Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TPMT | P51580 | 1/20 | 0.52 |
| ▸ | CES1 | P23141 | 1/20 | 0.48 |
| ▸ | ACHE | P22303 | 4/20 | 0.46 |
| ▸ | MLYCD | O95822 | 3/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | HCAR1 | Q9BXC0 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.39 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.39 |
| ▸ | C1S | P09871 | 1/20 | 0.39 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12086472 | 0.89 | CES1 (0.43) | TPMTCES1ACHEMLYCDCA2 | |
| SCHEMBL16449232 | 0.84 | TPMT (0.50) | TPMTACHECA2HCAR1HPGD | |
| SCHEMBL17963435 | 0.82 | NQO2 (0.41) | CES1ACHEMLYCD | |
| SCHEMBL19457495 | 0.82 | HDAC4 (0.41) | TPMTCES1ACHEMLYCD | |
| SCHEMBL30101218 | 0.82 | NQO2 (0.41) | CES1ACHEMLYCD | |
| SCHEMBL19268218 | 0.79 | CES1 (0.46) | CES1ACHEMLYCD | |
| SCHEMBL312610 | 0.79 | ACHE (0.62) | CES1ACHEHPGD | |
| SCHEMBL13543174 | 0.78 | TPMT (0.54) | TPMTHCAR1HPGDPRSS1PRSS2 | |
| SCHEMBL4190560 | 0.77 | CES1 (0.45) | CES1ACHEMLYCDCA2 | |
| SCHEMBL3473330 | 0.77 | HCAR2 (0.60) | CES1ACHEMLYCD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10441946-B2 | Linear alpha-olefin catalysts and preparation and use thereof | APALENE TECHNOLOGY CO., LTD. (HANGZHOU) (CN) | 2019-10-15 | — | — | US | disclosed |
| CN-105797773-B | Novel linear alhpa olefin catalyst and its preparation process and purposes | 亚培烯科技（杭州）有限公司 | 2018-11-06 | — | — | CN | disclosed |
| US-20180147571-A1 | NOVEL LINEAR ALPHA-OLEFIN CATALYSTS AND PREPARATION AND USE THEREOF | APALENE TECHNOLOGY CO., LTD. (JIAXING) (CN) | 2018-05-31 | — | — | US | disclosed |
| CN-105797774-B | Novel linear alhpa olefin catalyst and its preparation and commercial Application | 亚培烯科技(嘉兴)有限公司 | 2018-03-13 | — | — | CN | disclosed |
| CN-105728045-B | Novel linear alhpa olefin catalyst and its preparation method and application | 亚培烯科技(嘉兴)有限公司 | 2017-09-22 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180147571-A1 | NOVEL LINEAR ALPHA-OLEFIN CATALYSTS AND PREPARATION AND USE THEREOF | UBE2L3, RNF168, AGL | TPMT 4467/4885CES1 3464/4885ACHE 2736/4885 |
| US-10441946-B2 | Linear alpha-olefin catalysts and preparation and use thereof | UBE2L3, COG8, ACSL3 | TPMT 4363/4885CES1 3277/4885ACHE 2780/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.